药理和非药理干预对慢性阻塞性肺病 (COPD) 患者死亡率的影响
Maeva Zysman1, Guillaume Mahay2, Nicolas Guibert3
1Service de Pneumologie, CHU Haut-Lévèque, Bordeaux, France; Univ. Bordeaux, Centre de Recherche cardio-thoracique, INSERM U1045, CIC 1401, Pessac, France.
药理和非药理干预可以改善慢性阻塞性肺病 (COPD) 的存活率. 关键策略包括吸入类固醇,接种疫苗,长期氧气治疗,戒烟和营养支持,以更好地管理COPD.
科学领域:
- 肺部病理学 肺部病理学
- 药理学 药理学是指药理学的学科.
- 关键护理医学 关键护理医学
背景情况:
- 慢性阻塞性肺病 (COPD) 显著影响患者的生存率.
- 确定有效的COPD生存干预措施对于患者的治疗结果至关重要.
研究的目的:
- 审查对影响COPD患者生存的药理和非药理干预措施的证据.
- 确定有最大潜力改善COPD生存率的干预措施.
主要方法:
- 进行了叙事文学评论.
- 该审查综合了影响COPD存活率的各种干预措施的发现.
主要成果:
- 吸入性皮质类固醇,流感和肺炎球菌疫苗接种以及长期氧气疗法 (LTOT) 表明对COPD存活率有积极影响.
- 戒烟,遵守治疗和营养支持也可以提高存活率.
- β抑制剂没有增加COPD死亡率和潜在的心血管益处;他类药物的益处仅限于联合心血管疾病.
结论:
- 虽然一些干预措施显示出希望,但许多研究并没有将生存作为主要终点优先考虑.
- 进一步的长期研究是必要的,以充分理解优化COPD生存的全球管理策略.
更多相关视频
04:59Heat-sensitive Moxibustion as a Traditional Chinese Medicine Therapy for Chronic Obstructive Pulmonary Disease Combined with Insomnia
Published on: May 30, 2025
09:42Using Continuous Data Tracking Technology to Study Exercise Adherence in Pulmonary Rehabilitation
Published on: November 8, 2013
相关概念视频
COPD: Management Using Bronchodilators and Corticosteroids
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Chronic Obstructive Pulmonary Disease-V: Nursing Management
Assessment
Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
